On Friday, Myriad Genetics, Inc (NASDAQ: MYGN) was 6.96% up from the session before settling in for the closing price of $6.9. A 52-week range for MYGN has been $3.76 – $16.83.
When this article was written, the company’s average yearly earnings per share was at -96.59%. With a float of $88.69 million, this company’s outstanding shares have now reached $93.10 million.
Myriad Genetics, Inc (MYGN) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Myriad Genetics, Inc stocks. The insider ownership of Myriad Genetics, Inc is 4.85%, while institutional ownership is 97.85%.
Myriad Genetics, Inc (MYGN) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 0.03 earnings per share (EPS) during the time that was better than consensus figure (set at 0.03) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
Myriad Genetics, Inc (NASDAQ: MYGN) Trading Performance Indicators
You can see what Myriad Genetics, Inc (MYGN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.33, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach 0.06 in one year’s time.
Technical Analysis of Myriad Genetics, Inc (MYGN)
Myriad Genetics, Inc (NASDAQ: MYGN) saw its 5-day average volume 1.29 million, a negative change from its year-to-date volume of 1.61 million. As of the previous 9 days, the stock’s Stochastic %D was 66.72%.
During the past 100 days, Myriad Genetics, Inc’s (MYGN) raw stochastic average was set at 74.95%, which indicates a significant decrease from 85.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.48 in the past 14 days, which was higher than the 0.38 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.46, while its 200-day Moving Average is $7.17. Nevertheless, the first resistance level for the watch stands at $7.64 in the near term. At $7.90, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.31. If the price goes on to break the first support level at $6.97, it is likely to go to the next support level at $6.56. The third support level lies at $6.30 if the price breaches the second support level.
Myriad Genetics, Inc (NASDAQ: MYGN) Key Stats
There are 93,214K outstanding shares of the company, which has a market capitalization of 687.92 million. As of now, sales total 837,600 K while income totals -127,300 K. Its latest quarter income was 205,700 K while its last quarter net income were -27,400 K.
